Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia von Sekeres, Mikkael A, Lancet, Jeffrey E, Wood, Brent L, Grove, Laurie E, Sandalic, Larissa, Sievers, Eric L, Jurcic, Joseph G

Volltext

561P Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours von LoRusso, P., Fakih, M., De Vos, F.Y.F.L., Beck, J.T., Merchan, J., Shapiro, G., Lin, C-C., Desai, J., Spratlin, J., Cascella, T., Sandalic, L., Abdelhady, A.M., Boran, A., Gasal, E., Janku, F., Van Cutsem, E.

Volltext

Serum cathepsin B (CB) levels are prognostic in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2 von Singer, J. W., Oldham, F. B., Bandstra, B., Sandalic, L., Bianco, J., Bonomi, P., Ross, H.

Volltext

Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naive advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2 von Ross, H., Oldham, F. B., Bandstra, B., Sandalic, L., Bianco, J., Bonomi, P., Singer, J. W.

Volltext

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations von Bouffet, E, Hansford, JR, Garrè, ML, Hara, J, Plant-Fox, A, Aerts, I, Locatelli, F, van der Lugt, J, Papusha, L, Sahm, F, Tabori, U, Cohen, KJ, Packer, RJ, Witt, O, Sandalic, L, Bento Pereira da Silva, A, Russo, M, Hargrave, DR

Volltext bestellen

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemothe... von O'Brien, Mary E.R., Socinski, Mark A., Popovich, Alexander Y., Bondarenko, Igor N., Tomova, Antoaneta, Bilynsky˘ı, Borys T., Hotko, Yevhen S., Ganul, Valentin L., Kostinsky, Ippolit Y., Eisenfeld, Amy J., Sandalic, Larissa, Oldham, Fred B., Bandstra, Bruce, Sandler, Alan B., Singer, Jack W.

Volltext

Lintuzumab and Low-Dose Cytarabine Compared to Placebo and Low-Dose Cytarabine in Patients with Untreated Acute Myeloid Leukemia (AML) 60 Years and Older: Results of a Randomized,... von Lancet, Jeffrey E., Sekeres, Mikkael A., Wood, Brent L., Grove, Laurie E., Sandalic, Larissa, Sievers, Eric L., Jurcic, Joseph G.

Volltext